An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies-Reference-Cited by-同舟云学术

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Published:2021-06 Issue:13 Volume:184 Page:3452-3466.e18
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Liu Yafei,Soh Wai Tuck,Kishikawa Jun-ichi,Hirose Mika,Nakayama Emi E.,Li Songling,Sasai Miwa,Suzuki Tatsuya,Tada Asa,Arakawa Akemi,Matsuoka Sumiko,Akamatsu Kanako,Matsuda Makoto,Ono Chikako,Torii Shiho,Kishida Kazuki,Jin Hui,Nakai Wataru,Arase Noriko,Nakagawa Atsushi,Matsumoto Maki,Nakazaki Yukoh,Shindo Yasuhiro,Kohyama Masako,Tomii Keisuke,Ohmura Koichiro,Ohshima Shiro,Okamoto Toru,Yamamoto Masahiro,Nakagami Hironori,Matsuura Yoshiharu,Nakagawa Atsushi,Kato Takayuki,Okada Masato,Standley Daron M.,Shioda Tatsuo,Arase Hisashi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. A protocol for information-driven antibody-antigen modelling with the HADDOCK2.4 webserver;Ambrosetti;arXiv,2020

2. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection;Anderson;Cell,2021

3. The role of IgG Fc receptors in antibody-dependent enhancement;Bournazos;Nat. Rev. Immunol.,2020

4. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability;Brouwer;Science,2020

5. Distinct conformational states of SARS-CoV-2 spike protein;Cai;Science,2020

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants;PLOS Pathogens;2024-09-05

3. Neoself-antigens are the primary target for autoreactive T cells in human lupus;Cell;2024-09

4. Enhancing RBD exposure and S1 shedding by an extremely conserved SARS-CoV-2 NTD epitope;Signal Transduction and Targeted Therapy;2024-08-28

5. Phase Separation-based Antiviral Decoy Particles as Basis for Programmable Broad-spectrum Therapeutics;2024-08-28